Global Cholera Vaccines Market Research Report 2026(Status and Outlook)
Cholera vaccines are vaccines that are effective at preventing cholera. For the first six months after vaccination they provide about 85 percent protection, which decreases to 50 percent or 62 percent during the first year.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Cholera Vaccines market size was estimated at USD 99.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cholera Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cholera Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cholera Vaccines market.
Global Cholera Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Shantha Biotechnics Private Limited
PaxVax, Inc.
Valneva SE
Merck and Co., Inc.
GlaxoSmithKline plc (GSK)
Astellas Pharma, Inc.
Pfizer, Inc.
Emergent BioSolutions, Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
Market Segmentation (by Type)
Dukoral
Shanchol
Vaxchora
Others
Market Segmentation (by Application)
Oral
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cholera Vaccines Market
Overview of the regional outlook of the Cholera Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cholera Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cholera Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Cholera Vaccines market size was estimated at USD 99.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cholera Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cholera Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cholera Vaccines market.
Global Cholera Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Shantha Biotechnics Private Limited
PaxVax, Inc.
Valneva SE
Merck and Co., Inc.
GlaxoSmithKline plc (GSK)
Astellas Pharma, Inc.
Pfizer, Inc.
Emergent BioSolutions, Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
Market Segmentation (by Type)
Dukoral
Shanchol
Vaxchora
Others
Market Segmentation (by Application)
Oral
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cholera Vaccines Market
Overview of the regional outlook of the Cholera Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cholera Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cholera Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cholera Vaccines
1.2 Key Market Segments
1.2.1 Cholera Vaccines Segment by Type
1.2.2 Cholera Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CHOLERA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cholera Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cholera Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CHOLERA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cholera Vaccines Product Life Cycle
3.3 Global Cholera Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Cholera Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cholera Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cholera Vaccines Market Competitive Situation and Trends
3.8.1 Cholera Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cholera Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CHOLERA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Cholera Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CHOLERA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cholera Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cholera Vaccines Market
5.7 ESG Ratings of Leading Companies
6 CHOLERA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cholera Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Cholera Vaccines Market Size by Type (2020-2025)
6.4 Global Cholera Vaccines Price by Type (2020-2025)
7 CHOLERA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cholera Vaccines Market Sales by Application (2020-2025)
7.3 Global Cholera Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Cholera Vaccines Sales Growth Rate by Application (2020-2025)
8 CHOLERA VACCINES MARKET SALES BY REGION
8.1 Global Cholera Vaccines Sales by Region
8.1.1 Global Cholera Vaccines Sales by Region
8.1.2 Global Cholera Vaccines Sales Market Share by Region
8.2 Global Cholera Vaccines Market Size by Region
8.2.1 Global Cholera Vaccines Market Size by Region
8.2.2 Global Cholera Vaccines Market Size by Region
8.3 North America
8.3.1 North America Cholera Vaccines Sales by Country
8.3.2 North America Cholera Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cholera Vaccines Sales by Country
8.4.2 Europe Cholera Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cholera Vaccines Sales by Region
8.5.2 Asia Pacific Cholera Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cholera Vaccines Sales by Country
8.6.2 South America Cholera Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cholera Vaccines Sales by Region
8.7.2 Middle East and Africa Cholera Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CHOLERA VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of Cholera Vaccines by Region(2020-2025)
9.2 Global Cholera Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Cholera Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cholera Vaccines Production
9.4.1 North America Cholera Vaccines Production Growth Rate (2020-2025)
9.4.2 North America Cholera Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cholera Vaccines Production
9.5.1 Europe Cholera Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe Cholera Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cholera Vaccines Production (2020-2025)
9.6.1 Japan Cholera Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan Cholera Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cholera Vaccines Production (2020-2025)
9.7.1 China Cholera Vaccines Production Growth Rate (2020-2025)
9.7.2 China Cholera Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Shantha Biotechnics Private Limited
10.1.1 Shantha Biotechnics Private Limited Basic Information
10.1.2 Shantha Biotechnics Private Limited Cholera Vaccines Product Overview
10.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Product Market Performance
10.1.4 Shantha Biotechnics Private Limited Business Overview
10.1.5 Shantha Biotechnics Private Limited SWOT Analysis
10.1.6 Shantha Biotechnics Private Limited Recent Developments
10.2 PaxVax, Inc.
10.2.1 PaxVax, Inc. Basic Information
10.2.2 PaxVax, Inc. Cholera Vaccines Product Overview
10.2.3 PaxVax, Inc. Cholera Vaccines Product Market Performance
10.2.4 PaxVax, Inc. Business Overview
10.2.5 PaxVax, Inc. SWOT Analysis
10.2.6 PaxVax, Inc. Recent Developments
10.3 Valneva SE
10.3.1 Valneva SE Basic Information
10.3.2 Valneva SE Cholera Vaccines Product Overview
10.3.3 Valneva SE Cholera Vaccines Product Market Performance
10.3.4 Valneva SE Business Overview
10.3.5 Valneva SE SWOT Analysis
10.3.6 Valneva SE Recent Developments
10.4 Merck and Co., Inc.
10.4.1 Merck and Co., Inc. Basic Information
10.4.2 Merck and Co., Inc. Cholera Vaccines Product Overview
10.4.3 Merck and Co., Inc. Cholera Vaccines Product Market Performance
10.4.4 Merck and Co., Inc. Business Overview
10.4.5 Merck and Co., Inc. Recent Developments
10.5 GlaxoSmithKline plc (GSK)
10.5.1 GlaxoSmithKline plc (GSK) Basic Information
10.5.2 GlaxoSmithKline plc (GSK) Cholera Vaccines Product Overview
10.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Product Market Performance
10.5.4 GlaxoSmithKline plc (GSK) Business Overview
10.5.5 GlaxoSmithKline plc (GSK) Recent Developments
10.6 Astellas Pharma, Inc.
10.6.1 Astellas Pharma, Inc. Basic Information
10.6.2 Astellas Pharma, Inc. Cholera Vaccines Product Overview
10.6.3 Astellas Pharma, Inc. Cholera Vaccines Product Market Performance
10.6.4 Astellas Pharma, Inc. Business Overview
10.6.5 Astellas Pharma, Inc. Recent Developments
10.7 Pfizer, Inc.
10.7.1 Pfizer, Inc. Basic Information
10.7.2 Pfizer, Inc. Cholera Vaccines Product Overview
10.7.3 Pfizer, Inc. Cholera Vaccines Product Market Performance
10.7.4 Pfizer, Inc. Business Overview
10.7.5 Pfizer, Inc. Recent Developments
10.8 Emergent BioSolutions, Inc.
10.8.1 Emergent BioSolutions, Inc. Basic Information
10.8.2 Emergent BioSolutions, Inc. Cholera Vaccines Product Overview
10.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Product Market Performance
10.8.4 Emergent BioSolutions, Inc. Business Overview
10.8.5 Emergent BioSolutions, Inc. Recent Developments
10.9 Mitsubishi Tanabe Pharma Corporation
10.9.1 Mitsubishi Tanabe Pharma Corporation Basic Information
10.9.2 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Overview
10.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Market Performance
10.9.4 Mitsubishi Tanabe Pharma Corporation Business Overview
10.9.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
10.10 Takeda Pharmaceutical Co., Ltd.
10.10.1 Takeda Pharmaceutical Co., Ltd. Basic Information
10.10.2 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Overview
10.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Market Performance
10.10.4 Takeda Pharmaceutical Co., Ltd. Business Overview
10.10.5 Takeda Pharmaceutical Co., Ltd. Recent Developments
11 CHOLERA VACCINES MARKET FORECAST BY REGION
11.1 Global Cholera Vaccines Market Size Forecast
11.2 Global Cholera Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cholera Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Cholera Vaccines Market Size Forecast by Region
11.2.4 South America Cholera Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cholera Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cholera Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cholera Vaccines by Type (2026-2035)
12.1.2 Global Cholera Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cholera Vaccines by Type (2026-2035)
12.2 Global Cholera Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global Cholera Vaccines Sales (K Units) Forecast by Application
12.2.2 Global Cholera Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cholera Vaccines
1.2 Key Market Segments
1.2.1 Cholera Vaccines Segment by Type
1.2.2 Cholera Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CHOLERA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cholera Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cholera Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CHOLERA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cholera Vaccines Product Life Cycle
3.3 Global Cholera Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Cholera Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cholera Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cholera Vaccines Market Competitive Situation and Trends
3.8.1 Cholera Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cholera Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CHOLERA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Cholera Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CHOLERA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cholera Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cholera Vaccines Market
5.7 ESG Ratings of Leading Companies
6 CHOLERA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cholera Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Cholera Vaccines Market Size by Type (2020-2025)
6.4 Global Cholera Vaccines Price by Type (2020-2025)
7 CHOLERA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cholera Vaccines Market Sales by Application (2020-2025)
7.3 Global Cholera Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Cholera Vaccines Sales Growth Rate by Application (2020-2025)
8 CHOLERA VACCINES MARKET SALES BY REGION
8.1 Global Cholera Vaccines Sales by Region
8.1.1 Global Cholera Vaccines Sales by Region
8.1.2 Global Cholera Vaccines Sales Market Share by Region
8.2 Global Cholera Vaccines Market Size by Region
8.2.1 Global Cholera Vaccines Market Size by Region
8.2.2 Global Cholera Vaccines Market Size by Region
8.3 North America
8.3.1 North America Cholera Vaccines Sales by Country
8.3.2 North America Cholera Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cholera Vaccines Sales by Country
8.4.2 Europe Cholera Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cholera Vaccines Sales by Region
8.5.2 Asia Pacific Cholera Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cholera Vaccines Sales by Country
8.6.2 South America Cholera Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cholera Vaccines Sales by Region
8.7.2 Middle East and Africa Cholera Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CHOLERA VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of Cholera Vaccines by Region(2020-2025)
9.2 Global Cholera Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Cholera Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cholera Vaccines Production
9.4.1 North America Cholera Vaccines Production Growth Rate (2020-2025)
9.4.2 North America Cholera Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cholera Vaccines Production
9.5.1 Europe Cholera Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe Cholera Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cholera Vaccines Production (2020-2025)
9.6.1 Japan Cholera Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan Cholera Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cholera Vaccines Production (2020-2025)
9.7.1 China Cholera Vaccines Production Growth Rate (2020-2025)
9.7.2 China Cholera Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Shantha Biotechnics Private Limited
10.1.1 Shantha Biotechnics Private Limited Basic Information
10.1.2 Shantha Biotechnics Private Limited Cholera Vaccines Product Overview
10.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Product Market Performance
10.1.4 Shantha Biotechnics Private Limited Business Overview
10.1.5 Shantha Biotechnics Private Limited SWOT Analysis
10.1.6 Shantha Biotechnics Private Limited Recent Developments
10.2 PaxVax, Inc.
10.2.1 PaxVax, Inc. Basic Information
10.2.2 PaxVax, Inc. Cholera Vaccines Product Overview
10.2.3 PaxVax, Inc. Cholera Vaccines Product Market Performance
10.2.4 PaxVax, Inc. Business Overview
10.2.5 PaxVax, Inc. SWOT Analysis
10.2.6 PaxVax, Inc. Recent Developments
10.3 Valneva SE
10.3.1 Valneva SE Basic Information
10.3.2 Valneva SE Cholera Vaccines Product Overview
10.3.3 Valneva SE Cholera Vaccines Product Market Performance
10.3.4 Valneva SE Business Overview
10.3.5 Valneva SE SWOT Analysis
10.3.6 Valneva SE Recent Developments
10.4 Merck and Co., Inc.
10.4.1 Merck and Co., Inc. Basic Information
10.4.2 Merck and Co., Inc. Cholera Vaccines Product Overview
10.4.3 Merck and Co., Inc. Cholera Vaccines Product Market Performance
10.4.4 Merck and Co., Inc. Business Overview
10.4.5 Merck and Co., Inc. Recent Developments
10.5 GlaxoSmithKline plc (GSK)
10.5.1 GlaxoSmithKline plc (GSK) Basic Information
10.5.2 GlaxoSmithKline plc (GSK) Cholera Vaccines Product Overview
10.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Product Market Performance
10.5.4 GlaxoSmithKline plc (GSK) Business Overview
10.5.5 GlaxoSmithKline plc (GSK) Recent Developments
10.6 Astellas Pharma, Inc.
10.6.1 Astellas Pharma, Inc. Basic Information
10.6.2 Astellas Pharma, Inc. Cholera Vaccines Product Overview
10.6.3 Astellas Pharma, Inc. Cholera Vaccines Product Market Performance
10.6.4 Astellas Pharma, Inc. Business Overview
10.6.5 Astellas Pharma, Inc. Recent Developments
10.7 Pfizer, Inc.
10.7.1 Pfizer, Inc. Basic Information
10.7.2 Pfizer, Inc. Cholera Vaccines Product Overview
10.7.3 Pfizer, Inc. Cholera Vaccines Product Market Performance
10.7.4 Pfizer, Inc. Business Overview
10.7.5 Pfizer, Inc. Recent Developments
10.8 Emergent BioSolutions, Inc.
10.8.1 Emergent BioSolutions, Inc. Basic Information
10.8.2 Emergent BioSolutions, Inc. Cholera Vaccines Product Overview
10.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Product Market Performance
10.8.4 Emergent BioSolutions, Inc. Business Overview
10.8.5 Emergent BioSolutions, Inc. Recent Developments
10.9 Mitsubishi Tanabe Pharma Corporation
10.9.1 Mitsubishi Tanabe Pharma Corporation Basic Information
10.9.2 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Overview
10.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Market Performance
10.9.4 Mitsubishi Tanabe Pharma Corporation Business Overview
10.9.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
10.10 Takeda Pharmaceutical Co., Ltd.
10.10.1 Takeda Pharmaceutical Co., Ltd. Basic Information
10.10.2 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Overview
10.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Market Performance
10.10.4 Takeda Pharmaceutical Co., Ltd. Business Overview
10.10.5 Takeda Pharmaceutical Co., Ltd. Recent Developments
11 CHOLERA VACCINES MARKET FORECAST BY REGION
11.1 Global Cholera Vaccines Market Size Forecast
11.2 Global Cholera Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cholera Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Cholera Vaccines Market Size Forecast by Region
11.2.4 South America Cholera Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cholera Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cholera Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cholera Vaccines by Type (2026-2035)
12.1.2 Global Cholera Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cholera Vaccines by Type (2026-2035)
12.2 Global Cholera Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global Cholera Vaccines Sales (K Units) Forecast by Application
12.2.2 Global Cholera Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cholera Vaccines Market Size by Type (M USD)
Table 4. Global Cholera Vaccines Market Size by Application
Table 5. Cholera Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Cholera Vaccines Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cholera Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cholera Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cholera Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholera Vaccines as of 2025)
Table 11. Global Market Cholera Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cholera Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cholera Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cholera Vaccines Sales by Type (K Units)
Table 27. Global Cholera Vaccines Market Size by Type (M USD)
Table 28. Global Cholera Vaccines Sales (K Units) by Type (2020-2025)
Table 29. Global Cholera Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Cholera Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Cholera Vaccines Market Share by Type (2020-2025)
Table 32. Global Cholera Vaccines Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cholera Vaccines Sales (K Units) by Application
Table 34. Global Cholera Vaccines Market Size by Application
Table 35. Global Cholera Vaccines Sales by Application (2020-2025) & (K Units)
Table 36. Global Cholera Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Cholera Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cholera Vaccines Market Share by Application (2020-2025)
Table 39. Global Cholera Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Cholera Vaccines Sales by Region (2020-2025) & (K Units)
Table 41. Global Cholera Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Cholera Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cholera Vaccines Market Size by Region (2020-2025)
Table 44. North America Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. North America Cholera Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cholera Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cholera Vaccines Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cholera Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 51. South America Cholera Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cholera Vaccines Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cholera Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cholera Vaccines Production (K Units) by Region(2020-2025)
Table 55. Global Cholera Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cholera Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Cholera Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cholera Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cholera Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cholera Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cholera Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Shantha Biotechnics Private Limited Basic Information
Table 63. Shantha Biotechnics Private Limited Cholera Vaccines Product Overview
Table 64. Shantha Biotechnics Private Limited Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Shantha Biotechnics Private Limited Business Overview
Table 66. Shantha Biotechnics Private Limited SWOT Analysis
Table 67. Shantha Biotechnics Private Limited Recent Developments
Table 68. PaxVax, Inc. Basic Information
Table 69. PaxVax, Inc. Cholera Vaccines Product Overview
Table 70. PaxVax, Inc. Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. PaxVax, Inc. Business Overview
Table 72. PaxVax, Inc. SWOT Analysis
Table 73. PaxVax, Inc. Recent Developments
Table 74. Valneva SE Basic Information
Table 75. Valneva SE Cholera Vaccines Product Overview
Table 76. Valneva SE Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Valneva SE Business Overview
Table 78. Valneva SE SWOT Analysis
Table 79. Valneva SE Recent Developments
Table 80. Merck and Co., Inc. Basic Information
Table 81. Merck and Co., Inc. Cholera Vaccines Product Overview
Table 82. Merck and Co., Inc. Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Merck and Co., Inc. Business Overview
Table 84. Merck and Co., Inc. Recent Developments
Table 85. GlaxoSmithKline plc (GSK) Basic Information
Table 86. GlaxoSmithKline plc (GSK) Cholera Vaccines Product Overview
Table 87. GlaxoSmithKline plc (GSK) Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. GlaxoSmithKline plc (GSK) Business Overview
Table 89. GlaxoSmithKline plc (GSK) Recent Developments
Table 90. Astellas Pharma, Inc. Basic Information
Table 91. Astellas Pharma, Inc. Cholera Vaccines Product Overview
Table 92. Astellas Pharma, Inc. Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Astellas Pharma, Inc. Business Overview
Table 94. Astellas Pharma, Inc. Recent Developments
Table 95. Pfizer, Inc. Basic Information
Table 96. Pfizer, Inc. Cholera Vaccines Product Overview
Table 97. Pfizer, Inc. Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Pfizer, Inc. Business Overview
Table 99. Pfizer, Inc. Recent Developments
Table 100. Emergent BioSolutions, Inc. Basic Information
Table 101. Emergent BioSolutions, Inc. Cholera Vaccines Product Overview
Table 102. Emergent BioSolutions, Inc. Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Emergent BioSolutions, Inc. Business Overview
Table 104. Emergent BioSolutions, Inc. Recent Developments
Table 105. Mitsubishi Tanabe Pharma Corporation Basic Information
Table 106. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Overview
Table 107. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 109. Mitsubishi Tanabe Pharma Corporation Recent Developments
Table 110. Takeda Pharmaceutical Co., Ltd. Basic Information
Table 111. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Overview
Table 112. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Takeda Pharmaceutical Co., Ltd. Business Overview
Table 114. Takeda Pharmaceutical Co., Ltd. Recent Developments
Table 115. Global Cholera Vaccines Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Cholera Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Cholera Vaccines Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Cholera Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Cholera Vaccines Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Cholera Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Cholera Vaccines Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Cholera Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Cholera Vaccines Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Cholera Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Cholera Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Cholera Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Cholera Vaccines Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Cholera Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Cholera Vaccines Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Cholera Vaccines Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Cholera Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cholera Vaccines Market Size by Type (M USD)
Table 4. Global Cholera Vaccines Market Size by Application
Table 5. Cholera Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Cholera Vaccines Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cholera Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cholera Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cholera Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholera Vaccines as of 2025)
Table 11. Global Market Cholera Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cholera Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cholera Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cholera Vaccines Sales by Type (K Units)
Table 27. Global Cholera Vaccines Market Size by Type (M USD)
Table 28. Global Cholera Vaccines Sales (K Units) by Type (2020-2025)
Table 29. Global Cholera Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Cholera Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Cholera Vaccines Market Share by Type (2020-2025)
Table 32. Global Cholera Vaccines Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cholera Vaccines Sales (K Units) by Application
Table 34. Global Cholera Vaccines Market Size by Application
Table 35. Global Cholera Vaccines Sales by Application (2020-2025) & (K Units)
Table 36. Global Cholera Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Cholera Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cholera Vaccines Market Share by Application (2020-2025)
Table 39. Global Cholera Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Cholera Vaccines Sales by Region (2020-2025) & (K Units)
Table 41. Global Cholera Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Cholera Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cholera Vaccines Market Size by Region (2020-2025)
Table 44. North America Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. North America Cholera Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cholera Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cholera Vaccines Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cholera Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 51. South America Cholera Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cholera Vaccines Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cholera Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cholera Vaccines Production (K Units) by Region(2020-2025)
Table 55. Global Cholera Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cholera Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Cholera Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cholera Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cholera Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cholera Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cholera Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Shantha Biotechnics Private Limited Basic Information
Table 63. Shantha Biotechnics Private Limited Cholera Vaccines Product Overview
Table 64. Shantha Biotechnics Private Limited Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Shantha Biotechnics Private Limited Business Overview
Table 66. Shantha Biotechnics Private Limited SWOT Analysis
Table 67. Shantha Biotechnics Private Limited Recent Developments
Table 68. PaxVax, Inc. Basic Information
Table 69. PaxVax, Inc. Cholera Vaccines Product Overview
Table 70. PaxVax, Inc. Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. PaxVax, Inc. Business Overview
Table 72. PaxVax, Inc. SWOT Analysis
Table 73. PaxVax, Inc. Recent Developments
Table 74. Valneva SE Basic Information
Table 75. Valneva SE Cholera Vaccines Product Overview
Table 76. Valneva SE Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Valneva SE Business Overview
Table 78. Valneva SE SWOT Analysis
Table 79. Valneva SE Recent Developments
Table 80. Merck and Co., Inc. Basic Information
Table 81. Merck and Co., Inc. Cholera Vaccines Product Overview
Table 82. Merck and Co., Inc. Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Merck and Co., Inc. Business Overview
Table 84. Merck and Co., Inc. Recent Developments
Table 85. GlaxoSmithKline plc (GSK) Basic Information
Table 86. GlaxoSmithKline plc (GSK) Cholera Vaccines Product Overview
Table 87. GlaxoSmithKline plc (GSK) Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. GlaxoSmithKline plc (GSK) Business Overview
Table 89. GlaxoSmithKline plc (GSK) Recent Developments
Table 90. Astellas Pharma, Inc. Basic Information
Table 91. Astellas Pharma, Inc. Cholera Vaccines Product Overview
Table 92. Astellas Pharma, Inc. Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Astellas Pharma, Inc. Business Overview
Table 94. Astellas Pharma, Inc. Recent Developments
Table 95. Pfizer, Inc. Basic Information
Table 96. Pfizer, Inc. Cholera Vaccines Product Overview
Table 97. Pfizer, Inc. Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Pfizer, Inc. Business Overview
Table 99. Pfizer, Inc. Recent Developments
Table 100. Emergent BioSolutions, Inc. Basic Information
Table 101. Emergent BioSolutions, Inc. Cholera Vaccines Product Overview
Table 102. Emergent BioSolutions, Inc. Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Emergent BioSolutions, Inc. Business Overview
Table 104. Emergent BioSolutions, Inc. Recent Developments
Table 105. Mitsubishi Tanabe Pharma Corporation Basic Information
Table 106. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Overview
Table 107. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 109. Mitsubishi Tanabe Pharma Corporation Recent Developments
Table 110. Takeda Pharmaceutical Co., Ltd. Basic Information
Table 111. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Overview
Table 112. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Takeda Pharmaceutical Co., Ltd. Business Overview
Table 114. Takeda Pharmaceutical Co., Ltd. Recent Developments
Table 115. Global Cholera Vaccines Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Cholera Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Cholera Vaccines Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Cholera Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Cholera Vaccines Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Cholera Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Cholera Vaccines Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Cholera Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Cholera Vaccines Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Cholera Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Cholera Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Cholera Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Cholera Vaccines Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Cholera Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Cholera Vaccines Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Cholera Vaccines Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Cholera Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cholera Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cholera Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Cholera Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Cholera Vaccines Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cholera Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cholera Vaccines Product Life Cycle
Figure 13. Cholera Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Cholera Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cholera Vaccines Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cholera Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Cholera Vaccines
Figure 19. Global Cholera Vaccines Market PEST Analysis
Figure 20. Global Cholera Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cholera Vaccines Market Share by Type
Figure 27. Sales Market Share of Cholera Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Cholera Vaccines by Type in 2025
Figure 29. Market Share of Cholera Vaccines by Type (2020-2025)
Figure 30. Market Share of Cholera Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cholera Vaccines Market Share by Application
Figure 33. Global Cholera Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Cholera Vaccines Sales Market Share by Application in 2025
Figure 35. Global Cholera Vaccines Market Share by Application (2020-2025)
Figure 36. Global Cholera Vaccines Market Share by Application in 2025
Figure 37. Global Cholera Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cholera Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Cholera Vaccines Market Size by Region (2020-2025)
Figure 40. North America Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cholera Vaccines Sales Market Share by Country in 2024
Figure 43. North America Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cholera Vaccines Market Size by Country in 2024
Figure 45. U.S. Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cholera Vaccines Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cholera Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cholera Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cholera Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cholera Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cholera Vaccines Market Size by Country in 2024
Figure 55. Germany Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cholera Vaccines Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cholera Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cholera Vaccines Market Size by Region in 2024
Figure 68. China Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cholera Vaccines Sales and Growth Rate (K Units)
Figure 79. South America Cholera Vaccines Sales Market Share by Country in 2024
Figure 80. South America Cholera Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Cholera Vaccines Market Size by Country in 2024
Figure 82. Brazil Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cholera Vaccines Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cholera Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cholera Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cholera Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cholera Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Cholera Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cholera Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cholera Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cholera Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cholera Vaccines Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cholera Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cholera Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cholera Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Cholera Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Cholera Vaccines Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Cholera Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cholera Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Cholera Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Cholera Vaccines Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cholera Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cholera Vaccines Product Life Cycle
Figure 13. Cholera Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Cholera Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cholera Vaccines Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cholera Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Cholera Vaccines
Figure 19. Global Cholera Vaccines Market PEST Analysis
Figure 20. Global Cholera Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cholera Vaccines Market Share by Type
Figure 27. Sales Market Share of Cholera Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Cholera Vaccines by Type in 2025
Figure 29. Market Share of Cholera Vaccines by Type (2020-2025)
Figure 30. Market Share of Cholera Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cholera Vaccines Market Share by Application
Figure 33. Global Cholera Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Cholera Vaccines Sales Market Share by Application in 2025
Figure 35. Global Cholera Vaccines Market Share by Application (2020-2025)
Figure 36. Global Cholera Vaccines Market Share by Application in 2025
Figure 37. Global Cholera Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cholera Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Cholera Vaccines Market Size by Region (2020-2025)
Figure 40. North America Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cholera Vaccines Sales Market Share by Country in 2024
Figure 43. North America Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cholera Vaccines Market Size by Country in 2024
Figure 45. U.S. Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cholera Vaccines Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cholera Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cholera Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cholera Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cholera Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cholera Vaccines Market Size by Country in 2024
Figure 55. Germany Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cholera Vaccines Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cholera Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cholera Vaccines Market Size by Region in 2024
Figure 68. China Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cholera Vaccines Sales and Growth Rate (K Units)
Figure 79. South America Cholera Vaccines Sales Market Share by Country in 2024
Figure 80. South America Cholera Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Cholera Vaccines Market Size by Country in 2024
Figure 82. Brazil Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cholera Vaccines Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cholera Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cholera Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cholera Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cholera Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cholera Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cholera Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Cholera Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cholera Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cholera Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cholera Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cholera Vaccines Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cholera Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cholera Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cholera Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Cholera Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Cholera Vaccines Market Share Forecast by Application (2026-2035)
